116 related articles for article (PubMed ID: 7903456)
1. Dopamine D1 receptor family agonists, SK&F38393, SK&F77434, and SK&F82958, differentially affect locomotor activities in rats.
Meyer ME; Shults JM
Pharmacol Biochem Behav; 1993 Oct; 46(2):269-74. PubMed ID: 7903456
[TBL] [Abstract][Full Text] [Related]
2. Effects of intraaccumbens dopamine agonist SK&F38393 and antagonist SCH23390 on locomotor activities in rats.
Meyer ME
Pharmacol Biochem Behav; 1993 Aug; 45(4):843-7. PubMed ID: 8105489
[TBL] [Abstract][Full Text] [Related]
3. Effects of dopamine D1 antagonists SCH23390 and SK&F83566 on locomotor activities in rats.
Meyer ME; Cottrell GA; Van Hartesveldt C; Potter TJ
Pharmacol Biochem Behav; 1993 Feb; 44(2):429-32. PubMed ID: 8446676
[TBL] [Abstract][Full Text] [Related]
4. Locomotor activity following intra-accumbens microinjections of dopamine D1 agonist SK&F 38393 in rats.
Meyer ME; Van Hartesveldt C; Potter TJ
Synapse; 1993 Apr; 13(4):310-4. PubMed ID: 8097596
[TBL] [Abstract][Full Text] [Related]
5. Prefrontal, accumbal [shell] and ventral striatal mechanisms in jaw movements and non-cyclase-coupled dopamine D1-like receptors.
Adachi K; Hasegawa M; Fujita S; Lee J; Cools AR; Waddington JL; Koshikawa N
Eur J Pharmacol; 2003 Jul; 473(1):47-54. PubMed ID: 12877937
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the D1-dopamine agonists SKF-38393 and A-68930 in neonatal 6-hydroxydopamine-lesioned rats: behavioral effects and induction of c-fos-like immunoreactivity.
Johnson KB; Criswell HE; Jensen KF; Simson PE; Mueller RA; Breese GR
J Pharmacol Exp Ther; 1992 Aug; 262(2):855-65. PubMed ID: 1354257
[TBL] [Abstract][Full Text] [Related]
7. SK&F 83822 distinguishes adenylyl cyclase from phospholipase C-coupled dopamine D1-like receptors: behavioural topography.
O'Sullivan GJ; Roth BL; Kinsella A; Waddington JL
Eur J Pharmacol; 2004 Feb; 486(3):273-80. PubMed ID: 14985049
[TBL] [Abstract][Full Text] [Related]
8. Topographical resolution of jaw movements mediated by cyclase- vs. non-cyclase-coupled dopamine D(1)-like receptors: studies with SK&F 83822.
Fujita S; Lee J; Kiguchi M; Uchida T; Cools AR; Waddington JL; Koshikawa N
Eur J Pharmacol; 2006 May; 538(1-3):94-100. PubMed ID: 16682023
[TBL] [Abstract][Full Text] [Related]
9. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density.
LaHoste GJ; Marshall JF
Synapse; 1992 Sep; 12(1):14-26. PubMed ID: 1357762
[TBL] [Abstract][Full Text] [Related]
10. Catalepsy-associated behavior induced by dopamine D1 receptor antagonists and partial dopamine D1 receptor agonists in squirrel monkeys.
Rosenzweig-Lipson S; Bergman J
Eur J Pharmacol; 1994 Aug; 260(2-3):237-41. PubMed ID: 7988649
[TBL] [Abstract][Full Text] [Related]
11. Ventral striatal vs. accumbal (shell) mechanisms and non-cyclase-coupled dopamine D(1)-like receptors in jaw movements.
Hasegawa M; Adachi K; Nakamura S; Sato M; Waddington JL; Koshikawa N
Eur J Pharmacol; 2001 Jul; 423(2-3):171-8. PubMed ID: 11448482
[TBL] [Abstract][Full Text] [Related]
12. Hyperthermia induced by the dopamine D1 receptor agonist SK&F38393 in combination with the dopamine D2 receptor agonist talipexole in the rat.
Nagashima M; Yamada K; Kimura H; Matsumoto S; Furukawa T
Pharmacol Biochem Behav; 1992 Dec; 43(4):993-7. PubMed ID: 1361996
[TBL] [Abstract][Full Text] [Related]
13. Fetal behavior and the dopamine system: activity effects of D1 and D2 receptor manipulations.
Moody CA; Robinson SR; Spear LP; Smotherman WP
Pharmacol Biochem Behav; 1993 Apr; 44(4):843-50. PubMed ID: 8097042
[TBL] [Abstract][Full Text] [Related]
14. Place conditioning with the dopamine D1-like receptor agonist SKF 82958 but not SKF 81297 or SKF 77434.
Abrahams BS; Rutherford JD; Mallet PE; Beninger RJ
Eur J Pharmacol; 1998 Feb; 343(2-3):111-8. PubMed ID: 9570457
[TBL] [Abstract][Full Text] [Related]
15. Dopamine D1 receptor involvement in the discriminative-stimulus effects of SKF 81297 in squirrel monkeys.
Rosenzweig-Lipson S; Bergman J
J Pharmacol Exp Ther; 1993 Nov; 267(2):765-75. PubMed ID: 7902432
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of stereotyped behavior and production of latent locomotor behaviors in mice treated continuously with quinpirole.
Zhou LW; Qin ZH; Weiss B
Neuropsychopharmacology; 1991 Jan; 4(1):47-55. PubMed ID: 1672250
[TBL] [Abstract][Full Text] [Related]
17. The anorectic effect of SK&F 38393, a selective dopamine D1 receptor agonist: a microstructural analysis of feeding and related behaviour.
Cooper SJ; Francis J; Rusk IN
Psychopharmacology (Berl); 1990; 100(2):182-7. PubMed ID: 1968277
[TBL] [Abstract][Full Text] [Related]
18. (+/-)-3-Allyl-6-bromo-7,8-dihydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3- benzazepin, a new high-affinity D1 dopamine receptor ligand: synthesis and structure-activity relationship.
Neumeyer JL; Baindur N; Niznik HB; Guan HC; Seeman P
J Med Chem; 1991 Dec; 34(12):3366-71. PubMed ID: 1684995
[TBL] [Abstract][Full Text] [Related]
19. Grooming and vacuous chewing induced by SK&F 83959, an agonist of dopamine 'D1-like' receptors that inhibits dopamine-sensitive adenylyl cyclase.
Downes RP; Waddington JL
Eur J Pharmacol; 1993 Mar; 234(1):135-6. PubMed ID: 8097163
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological characterization of behavioural responses to SK&F 83959 in relation to 'D1-like' dopamine receptors not linked to adenylyl cyclase.
Deveney AM; Waddington JL
Br J Pharmacol; 1995 Oct; 116(3):2120-6. PubMed ID: 8640354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]